TERTIARY STRUCTURE DATA |
Homo sapiens
|
tetramer |
3.00 Å |
1A0L |
1A0L |
1A0L |
1A0L |
1A0L |
1A0L |
Pereira et al., 1998 |
theoretical model |
0.00 Å |
1AAO |
1AAO |
1AAO |
1AAO |
1AAO |
1AAO |
|
human beta-ii tryptase in complex with 4-(3-aminomethyl- phenyl)-piperidin-1-yl-(5-phenethyl- pyridin-3-yl)- methanone |
2.20 Å |
2BM2 |
2BM2 |
2BM2 |
2BM2 |
2BM2 |
2BM2 |
Levell et al., 2005 |
human tryptase with 2-amino benzimidazole |
2.00 Å |
2FPZ |
2FPZ |
2FPZ |
2FPZ |
2FPZ |
2FPZ |
McGrath et al., 2006 |
human beta-tryptase ii with inhibitor cra-29382 |
2.50 Å |
2FS8 |
2FS8 |
2FS8 |
2FS8 |
2FS8 |
2FS8 |
McGrath et al., 2006 |
human beta tryptase ii with inhibitor cra-28427 |
2.30 Å |
2FS9 |
2FS9 |
2FS9 |
2FS9 |
2FS9 |
2FS9 |
McGrath et al., 2006 |
complex with 4-piperidinebutyrate to make acylenzyme |
2.25 Å |
2FWW |
2FWW |
2FWW |
2FWW |
2FWW |
2FWW |
McGrath et al., 2006 |
complex with activated ketone inhibitor cra-29382 |
2.50 Å |
2FXR |
2FXR |
2FXR |
2FXR |
2FXR |
2FXR |
McGrath et al., 2006 |
human beta ii tryptase with inhibitor cra-27592 |
2.35 Å |
2GDD |
2GDD |
2GDD |
2GDD |
2GDD |
2GDD |
|
complex with (5-(aminomethyl)-2H-spiro[benzofuran-3,4'- piperidine]-1'-yl)(5-(phenylethynyl)furan- 2-yl)methanone |
2.30 Å |
2ZA5 |
2ZA5 |
2ZA5 |
2ZA5 |
2ZA5 |
2ZA5 |
Costanzo et al., 2003 |
potent, nonpeptide inhibitors of human mast cell tryptase |
2.50 Å |
2ZEB |
2ZEB |
2ZEB |
2ZEB |
2ZEB |
2ZEB |
Costanzo et al., 2008 |
potent, nonpeptide inhibitors of human mast cell tryptase |
2.06 Å |
2ZEC |
2ZEC |
2ZEC |
2ZEC |
2ZEC |
2ZEC |
Costanzo et al., 2008 |
mature peptidase |
2.09 Å |
3V7T |
3V7T |
3V7T |
3V7T |
3V7T |
3V7T |
Liang et al., 2012 |
complex with 5-(3-aminomethyl-phenoxymethyl)-3-[3-(2- chloro-pyridin-3-ylethynyl)-phenyl]-oxazolidin-2-one; compound with trifluoro-acetic acid |
1.94 Å |
5F03 |
5F03 |
5F03 |
5F03 |
5F03 |
5F03 |
|